The leading producer of over-the-counter cold medications in the US, has assured consumers that none of its Tylenol® or Motrin ® brand cold/flu or
sinus products contain phenylpropanolamine (PPA).
A panel of experts yesterday recommended that the U.S. Food and Drug
Administration ban PPA in over-the-counter appetite suppressants and
decongestants, because of a new study suggesting that this ingredient could be
related to some types of strokes. Others, including the leading organization
of OTC drug manufacturers and renowned epidemiologists, challenged the merits
of the study and denied that it could be used to suggest additional health
risks with this ingredient.
Because some early news announcements about the FDA panel recommendation
included footage showing Tylenol® products, to avoid confusion among
consumers, McNeil, the maker of Tylenol felt compelled to point out that its entire line of adult and pediatric Tylenol® and Motrin ® products is free of PPA.
Consumers having questions about Tylenol® or Motrin ® products can call